Philips North America LLC – FDA 483, Mar 25, 2020
Philips North America LLC in Bothell, WA, a medical device manufacturer, was cited for inadequate corrective and preventive action (CAPA) procedures. The firm failed to adequately establish procedures for CAPA, resulting in numerous Class 3 defibrillators being missed from Field Change Orders (FCOs) despite a Health Hazard Evaluation identifying a serious risk of injury or permanent impairment. The investigation into affected devices was significantly delayed, taking 355 days to identify all at-risk devices after determining a new FCO was required.
ID · 9f87ee6f-18b9-4d5c-a627-6a39cfa94005
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.